Medinol Revenue and Competitors

Tel Aviv, Israel

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Medinol's estimated annual revenue is currently $40.4M per year.(i)
  • Medinol's estimated revenue per employee is $251,000

Employee Data

  • Medinol has 161 Employees.(i)
  • Medinol grew their employee count by 5% last year.

Medinol's People

NameTitleEmail/Phone
1
Head Regulatory AffairsReveal Email/Phone
2
VP Innovative TechnologiesReveal Email/Phone
3
VP FinanceReveal Email/Phone
4
EVP Global CommercializationReveal Email/Phone
5
Head Quality AssuranceReveal Email/Phone
6
Head Labs and Technical ServicesReveal Email/Phone
7
Chief Operating OfficerReveal Email/Phone
8
HR Group ManagerReveal Email/Phone
9
Program ManagerReveal Email/Phone
10
Project ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$21.1M840%N/AN/A
#2
$5.6M450%$91.1MN/A
#3
$202.8M577-2%$632.9MN/A
#4
$21.3M85-29%$99.9MN/A
#5
$21.1M842%$128MN/A
#6
$22.3M891%N/AN/A
#7
$6.8M27-4%N/AN/A
#8
$5.8M23-12%N/AN/A
#9
$3.3M130%N/AN/A
#10
$1.3M50%N/AN/A
Add Company

What Is Medinol?

Medinol is dedicated to the science of cardiovascular intervention. For over 25 years, we have delivered over two million coronary stents to patients worldwide. Our products constantly stretch the limits of innovation and our cutting-edge technology continues to demonstrate extraordinary clinical results. We make our products in-house using proprietary manufacturing technologies that ensure consistently exceptional quality and safety. Medinol manufactures EluNIR™, the first elastomeric drug eluting stent. Now FDA approved and CE marked, EluNIR demonstrated excellent clinical outcomes and promising safety profile in two clinical studies and features the Flexx² catheter technology with a metallic spring-tip, resulting in unprecedented ease-of-delivery even in tough anatomies. A unique stent design provides low metal footprint and optimized vessel support, leveraged by an elastomeric coating that ensures excellent surface quality. Founded in 1992 by Dr. Judith Richter and Dr. Kobi Richter and privately held to this day, Medinol continues to benefit from the leadership and insight of its founders. With more than 300 employees on board, we proudly maintain our family spirit and entrepreneurial culture. Interested in joining Medinol ? Click the link below to visit our website

keywords:N/A

N/A

Total Funding

161

Number of Employees

$40.4M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Medinol News

2022-04-20 - Drug-Eluting Stents Market Size, Scope And Forecast | Boston ...

... Terumo Corporation, Biosensors International Group Ltd., Abbott, Medtronic, Biotronik, Medinol Ltd., Cook, STENTYS SA.

2022-04-19 - Occlusion Catheters Market Size 2022-2030| Key Players ...

The major players covered in Occlusion Catheters Markets: LeMaitre; ISO Med; Edwards Lifesciences; Medinol; Stryker; Arthesys; CooperSurgical...

2022-04-17 - Drug-Eluting Stents Market Size And Forecast | Boston ...

... MicroPort Scientific Corporation, Terumo Corporation, Biosensors International Group Ltd., Abbott, Medtronic, Biotronik, Medinol Ltd., Cook, STENTYS SA.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$58.4M1617%N/A
#2
$43.9M1631%N/A
#3
$26.2M16415%N/A
#4
$59.3M16627%N/A
#5
$73.5M16724%N/A